Senti Biosciences, Inc.
Developing smart cell and gene therapies with Gene Circuits to precisely target cancer.
SNTI | US
Overview
Corporate Details
- ISIN(s):
- US81726A1007
- LEI:
- Country:
- United States of America
- Address:
- 2 CORPORATE DRIVE, FIRST FLOOR, 94080 SOUTH SAN FRANCISCO
- Website:
- https://www.sentibio.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Senti Biosciences, Inc. is a clinical-stage biotechnology company developing a new generation of cell and gene therapies, referred to as "smarter medicines." The company's core technology is its proprietary Gene Circuit platform, which utilizes synthetic biology to reprogram cells with biological logic. These Gene Circuits are designed from novel DNA sequences to enable therapeutic cells to sense inputs, compute decisions, and respond to their specific cellular environments. Senti Bio's primary focus is on oncology, creating a pipeline of product candidates designed to precisely target and eliminate cancer cells while sparing healthy ones, aiming to provide potentially lifesaving treatments for patients with incurable diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Senti Biosciences, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Senti Biosciences, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Senti Biosciences, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
